Related Experiment Video
Updated: Sep 14, 2025
07:54
Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
20.0K
Sleep Medicine-What's in a Name?
Dirk A Pevernagie1,2, Erna Sif Arnardottir3, Oliviero Bruni4
1Department of Internal Medicine and Paediatrics, Faculty of Medicine and Health Sciences, Ghent University, Gent, Belgium.
Journal of Sleep Research
|July 19, 2025
Summary
Sleep medicine is a growing field addressing sleep disorders like insomnia and breathing issues. Future progress depends on innovation and overcoming challenges in care access and research funding.
Area of Science:
- Sleep medicine as a distinct medical discipline.
- Interdisciplinary approach to sleep physiology and disorders.
- Impact of sleep disturbances on overall health.
Background:
- Sleep medicine has evolved from various specialties into a recognized field.
- Significant advancements in understanding sleep physiology and disorders.
- Sleep disturbances affect all aspects of health and well-being.
Purpose of the Study:
- To review the current state of sleep medicine.
- To identify challenges and opportunities in the field.
- To discuss the future direction of sleep medicine.
Main Methods:
- Review of established diagnostic and therapeutic pathways.
- Analysis of professional standards, guidelines, and competency frameworks.
- Consideration of technological advancements and precision medicine.
Main Results:
- Sleep medicine is characterized by defined concepts, evidence-based treatments, and interdisciplinary collaboration.
- Major sleep disorder categories include insomnia, neurological/psychiatric disorders, sleep-disordered breathing, and pediatric sleep disorders.
- Systemic challenges persist, including limited access to care, inadequate funding, and insufficient research investment.
Conclusions:
- Sleep medicine is at a critical juncture, requiring a redefined mission and vision.
- Addressing structural shortcomings and embracing innovation are crucial for future progress.
- Affirming the essential role of sleep medicine in public health is paramount.
Related Concept Videos
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
245
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
245
01:23Sedatives and Hypnotics: Overview
659
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
659
01:19Sedatives and Hypnotics Drugs: Benzodiazepines
391
Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
391
01:19Management of Insomnia
323
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
323
01:20Sedatives and Hypnotics Drugs: Barbiturates
486
Sedatives and hypnotics encompass a drug class that acts on the central nervous system (CNS) to alleviate anxiety, promote relaxation and induce sleep.These drugs function by amplifying the actions of the neurotransmitter γ-aminobutyric acid (GABA), resulting in reduced neuronal activity. Barbiturates, a subset of sedatives and hypnotics first synthesized in the late 1800s, are categorized into ultra-short, short, intermediate, and long-acting groups based on their duration of effect. A...
486
01:14CNS Depressants: Barbiturates and Benzodiazepines
474
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
474